A meta-analysis of the effects of sacubitril-valsartan on surrogate markers of systemic right ventricular dysfunction in congenital heart disease

Back

ESC Professional Premium Access

A meta-analysis of the effects of sacubitril-valsartan on surrogate markers of systemic right ventricular dysfunction in congenital heart disease

Session: Optimising care in adult congenital heart disease

Topic: Pharmacotherapy

Speaker: Doctor B. Braganca (Guilhufe, PT)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Bruno Braganca

CH Tamega e Sousa - Penafiel, Guilhufe (Portugal)

0 follower

8 more presentations in this session

Optimising liver screening in patients with a Fontan circulation: a cost-effective approach to detection of Fontan associated liver disease which enhances patient care

Speaker: Mr H. Mathew (London, GB)

Effects of pulmonary hypertension targeted therapy on haemodynamics in pulmonary arterial hypertension associated with adult congenital heart disease: a meta-analysis

Speaker: Doctor L. Tsigkriki (Thessaloniki, GR)

A cohort study examining predictors of stroke and bleeding among people with congenital heart disease and atrial fibrillation

Speaker: Doctor M. O'Shea (Phoenix, US)

Reverse cardiac remodeling induced by endovascular treatment of coarctation of the aorta

Speaker: Assistant Professor M. Farrashi (Tehran, IR)

Cardiac resynchronization therapy in adult congenital heart disease: single center cohort study

Speaker: Doctor O. Rahat (Petah Tikva, IL)

Access the full session

Optimising care in adult congenital heart disease

Speakers: Doctor B. Braganca, Mr H. Mathew, Doctor L. Tsigkriki, Doctor M. O'Shea, Assistant Professor M. Farrashi...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources